Automated Dynamics, Corp Providing the highest level of technical application support

ADC Reps are factory representatives for the market leaders in factory and process automation products.

OVERVIEW

The site adcreps.com currently has an average traffic classification of zero (the lower the higher page views). We have analyzed six pages within the domain adcreps.com and found zero websites linking to adcreps.com. There are two contacts and directions for adcreps.com to help you communicate with them. There are one mass communication platforms enjoyed by adcreps.com. The site adcreps.com has been on the internet for one thousand two hundred and fifty-nine weeks, twenty-one days, two hours, and thirty-one minutes.
Pages Parsed
6
Contacts
2
Addresses
2
Social Links
1
Online Since
Mar 2000

ADCREPS.COM TRAFFIC

The site adcreps.com has seen alternating quantities of traffic until the end of the year.
Traffic for adcreps.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for adcreps.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for adcreps.com

Date Range

All time
This Year
Last Year
Last Month

ADCREPS.COM HISTORY

The site adcreps.com was registered on March 30, 2000. This site was updated on November 08, 2006. This web site will go back on the market on the date of March 30, 2016. It is currently one thousand two hundred and fifty-nine weeks, twenty-one days, two hours, and thirty-one minutes young.
REGISTERED
March
2000
UPDATED
November
2006
EXPIRED
March
2016

SPAN

24
YEARS
1
MONTHS
20
DAYS

LINKS TO WEBSITE

WHAT DOES ADCREPS.COM LOOK LIKE?

Desktop Screenshot of adcreps.com Mobile Screenshot of adcreps.com Tablet Screenshot of adcreps.com

CONTACTS

AUTOMATED DYNAMICS CORP.

330 N Sam Huston Prkway E #236

HUSTON, TX, 77060

US

AUTOMATED DYNAMICS CORP.

AUTOMATED DYNAMICS CORP.

330 N Sam Huston Prkway E #236

HUSTON, TX, 77060

US

ADCREPS.COM SERVER

We discovered that a single root page on adcreps.com took one thousand one hundred and thirty-nine milliseconds to load. Our parsers could not observe a SSL certificate, so our web crawlers consider adcreps.com not secure.
Load time
1.139 sec
SSL
NOT SECURE
IP
173.236.8.226

NAME SERVERS

ns77.worldnic.com
ns78.worldnic.com

SERVER SOFTWARE

We detected that this website is utilizing the Apache/2.2.29 (Unix) mod_ssl/2.2.29 OpenSSL/1.0.1e-fips mod_bwlimited/1.4 os.

HTML TITLE

Automated Dynamics, Corp Providing the highest level of technical application support

DESCRIPTION

ADC Reps are factory representatives for the market leaders in factory and process automation products.

PARSED CONTENT

The site adcreps.com states the following, "Turck offers a broad variety of molded Quick Disconnect Cables, Junction Boxes, and Receptacles." I noticed that the website also stated " From our 5mm Pentafast connectors to the Power Fast with ratings up 40 amps." They also stated " Standard offerings and custom assemblies to fit your connectivity requirements. N-Tron manufactures a broad family of Ethernet Switches designed specifically for industrial, marine, utility, and military users requiring high reliability, superior performance, and exceptional noise immunity." The meta header had Banner as the first keyword. This keyword was followed by Larco, Red Lion, and PULS which isn't as urgent as Banner. The other words the site used was Turck Works. Reps is also included but might not be understood by search crawlers.

ANALYZE MORE DOMAINS

Web Marketing Social Media Marketing

10000 Visite Italiane Sito Web. 5 Parole Chiave Posizionamento su Google. 5000 Contatti per Lead Generation. 60 Articoli per Article Marketing.

ADC Review Journal of Antibody-drug Conjugates ADC Review

Phase I Study Supports Therapeutic Potential of Polatuzumab Vedotin in non-Hodgkin Lymphoma. PSMA ADC Produces Clinically Relevant Declines in PSA and CTC Counts. Enhancing ADCs to Target Diseased Cells and Deliver Payloads. Seattle Genetics and Bristol-Myers Squibb Evaluate New Combination of Brentuximab Vedotin and Nivolumab. and Bristol-Myers Squibb Company have entered into a clinical trial collaboration to evaluate the investigational c.